| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/12/2007 | US20070160528 Method to evaluate the likelehood of development of bone metastasis based on the determination of calcium binding proteins |
| 07/12/2007 | DE4208258B4 Verfahren zur Herstellung von kristallinem Ciclosporin in kugelartiger Teilchenform und seine Verwendung, insbesondere zur pulmonalen Verabreichung A process for producing crystalline Ciclosporin in spheroidal particulate form and to its use, in particular for pulmonary administration |
| 07/12/2007 | DE102006001017A1 Use of glucose isomerase in combination with 5-D-fructose dehydrogenase and an enzyme, e.g. invertase, for producing a pharmaceutical composition for preventing, treating, or diagnosing diabetes |
| 07/12/2007 | DE102005056194A1 Neue Lipopeptid Zusammensetzungen New lipopeptide compositions |
| 07/12/2007 | CA2841386A1 Extended release of neuregulin for improved cardiac function |
| 07/12/2007 | CA2671322A1 Compositions and methods for treating actin-mediated medical conditions by administering an actin modulating agent |
| 07/12/2007 | CA2635618A1 Interleukin-12p40 variants with improved stability |
| 07/12/2007 | CA2635589A1 Protease inhibition |
| 07/12/2007 | CA2635562A1 Treatment of hiv using proopiomelanocortin (pomc) and corticotropin releasing factor (crf) and their products |
| 07/12/2007 | CA2634974A1 Extended release of neuregulin for improved cardiac function |
| 07/12/2007 | CA2633013A1 A method of treatment |
| 07/12/2007 | CA2632918A1 Method for preventing and/or treating articles or media contaminated with bacteria of the legionella genus |
| 07/12/2007 | CA2632832A1 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 07/12/2007 | CA2632826A1 Bacteriocin inducer peptides |
| 07/12/2007 | CA2630613A1 Cancer stem cells and uses thereof |
| 07/12/2007 | CA2630364A1 Methods of treating unwanted immune response with random copolymers |
| 07/11/2007 | EP1806404A1 Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/11/2007 | EP1806403A2 Human cancer antigen NY ESO 1/CAG-3 and gene encoding same |
| 07/11/2007 | EP1806402A2 CTLA4/CD28 ligands and uses therefor |
| 07/11/2007 | EP1806367A2 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/11/2007 | EP1806361A1 Erythropoietin liquid formulation |
| 07/11/2007 | EP1806360A2 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 07/11/2007 | EP1806357A1 Hypoxia inducible factor-1 and method of use |
| 07/11/2007 | EP1806356A2 Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators |
| 07/11/2007 | EP1806354A2 Amphoteric sterols and their use |
| 07/11/2007 | EP1806150A1 Teicoplanin composition |
| 07/11/2007 | EP1806147A1 Use of immunesuppressant receptor |
| 07/11/2007 | EP1806146A1 Agonists or antagonists of cutaneous T cell-attracting chemokine (CTACK) or vasoactive intestinal contractor (VIC) chemokines |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent |
| 07/11/2007 | EP1806142A1 Method for the production of (poly)peptides by using truncated variants of the SV 40 large T antigen with an intact N terminus |
| 07/11/2007 | EP1806141A1 Par-2 antagonists |
| 07/11/2007 | EP1806138A1 Anti-tumor agents comprising boroproline compounds |
| 07/11/2007 | EP1805309A2 C1q related protein |
| 07/11/2007 | EP1805215A2 Chemically modified peptide analogs |
| 07/11/2007 | EP1805214A2 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use |
| 07/11/2007 | EP1805210A1 Novel peptides and methods for the treatment of inflammatory disease |
| 07/11/2007 | EP1805209A2 Nogo-a polypeptide fragments, variant nogo receptor-1 polypeptides, and uses thereof |
| 07/11/2007 | EP1805208A2 Labeled compounds for proteasome inhibition |
| 07/11/2007 | EP1804832A2 Methods and compositions for needleless delivery of macromolecules |
| 07/11/2007 | EP1804828A2 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 07/11/2007 | EP1804827A1 Methods for treating cancer |
| 07/11/2007 | EP1804826A2 Treatment of neurological deficits in the striatum or substanta nigra pars compacta |
| 07/11/2007 | EP1804825A2 Treatment of neurological deficits in the striatum or substantia nigra pars compacta |
| 07/11/2007 | EP1804823A2 Novel cyclosporin analogues and their pharmaceutical uses |
| 07/11/2007 | EP1804822A1 Hcv vaccines for chronic hcv patients |
| 07/11/2007 | EP1804821A2 Hcv ns3-ns4a protease inhibition |
| 07/11/2007 | EP1804820A2 Vasoactive intestinal polypeptide pharmaceuticals |
| 07/11/2007 | EP1804818A1 Methods and compositions for use of angiogenesis inhibitors in the prevention and/or control of epilepsy |
| 07/11/2007 | EP1804817A2 Methods for promoting wound healing |
| 07/11/2007 | EP1804816A2 Combination therapy comprising cloretazine(tm) |
| 07/11/2007 | EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/11/2007 | EP1536763B1 Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent |
| 07/11/2007 | EP1535065A4 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/11/2007 | EP1455808B1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases |
| 07/11/2007 | EP1242108B1 Optimized minigenes and peptides encoded thereby |
| 07/11/2007 | EP1218504B1 Gl50 molecules and uses therefor |
| 07/11/2007 | EP1171576B1 Pseudomycin production by pseudomonas syringae |
| 07/11/2007 | EP1154788B1 Inhibitors of separin, method for identifying them and uses |
| 07/11/2007 | EP1146889B1 IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED MYCOBACTERIAL ANTIGENS AND MEDICAL USE OF THE MYCOBACTERIAL PROTEINS Rv0068 AND Rv3407 |
| 07/11/2007 | EP1141283B1 NOVEL METHOD FOrR IDENTIFICATION OF A COMPOUND MODULATING INTERACTION BETWEEN A TNF LIGAND AND ITS RECEPTOR ON B CELLS |
| 07/11/2007 | EP1105467B1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 07/11/2007 | EP1071767B1 Gene coding for heliomicine and use thereof |
| 07/11/2007 | EP1065270B1 HUMAN p51 GENES AND GENE PRODUCTS THEREOF |
| 07/11/2007 | EP0979246B1 Human monoclonal antibodies to epidermal growth factor receptor |
| 07/11/2007 | EP0975771B1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins |
| 07/11/2007 | EP0904352B1 Cell line |
| 07/11/2007 | EP0808367B1 Mucosal vascular addressins and uses thereof |
| 07/11/2007 | EP0577752B2 Human pf4a receptors and their use |
| 07/11/2007 | CN1997750A Blood pressure lowering oligopeptides |
| 07/11/2007 | CN1997748A Probiotic compounds from lactobacillus GG and uses therefor |
| 07/11/2007 | CN1997666A Polyethylene glycol modified interferon compositions and methods of use thereof |
| 07/11/2007 | CN1997665A Novel carbamylated EPO and method for its production |
| 07/11/2007 | CN1997664A Compounds that block the C5A receptor and their use in therapy |
| 07/11/2007 | CN1997662A Inhibitors based on fusion, HR1 and HR2 sequences in bacterial adhesin |
| 07/11/2007 | CN1997661A Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| 07/11/2007 | CN1997660A Myosin light chain kinase inhibitors and methods of use |
| 07/11/2007 | CN1997408A Wound care products containing keratin |
| 07/11/2007 | CN1997388A Mucinous glycoprotein (MUC-1) vaccine |
| 07/11/2007 | CN1997387A Methods and compositions for improving growth of meat-type poultry |
| 07/11/2007 | CN1997386A Methods of treating type I diabetes by blocking VEGF-mediated activity |
| 07/11/2007 | CN1997385A Annexin V for preventing atherothrombois and plaque rupture |
| 07/11/2007 | CN1997384A Treatment of neurological conditions using complement c5a receptor modulators |
| 07/11/2007 | CN1997383A Aequorin-containing compositions and methods of using same |
| 07/11/2007 | CN1997382A Bispecific binding agents for modulating biological activity |
| 07/11/2007 | CN1997381A Corneal neuritogenesis promoter containing PACAP and its derivative |
| 07/11/2007 | CN1997366A Imidazole and thiazole derivatives as antiviral agents |
| 07/11/2007 | CN1997361A Antitumor agent |
| 07/11/2007 | CN1997356A Sustained release formulations |
| 07/11/2007 | CN1997352A Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 07/11/2007 | CN1995354A Mycobacterium tuberculosis succinyl coenzymea A synthase gene and its uses |
| 07/11/2007 | CN1995345A Recombinant L-251 protein with anti-inflammatory effect secreted by Japanese lamprey oral gland |
| 07/11/2007 | CN1995340A Mycobacterium tuberculosis glucosamine-6-phosphate synthase gene and its uses |
| 07/11/2007 | CN1995337A Antibiotic protein beta-1-3,1-4-endoglucanase and lyase L27 and its uses |
| 07/11/2007 | CN1995065A Fusion protein for suppressing PTTG expression and its coding gene and uses |
| 07/11/2007 | CN1995064A Long-lasting recombinant human red blood cell growth factor fusion protein and method |
| 07/11/2007 | CN1994464A ACEI inhibitor and application thereof |
| 07/11/2007 | CN1994463A Preparation and use of immune formulation |
| 07/11/2007 | CN1994462A Anti-fatigue injection of zinc-metallothionein |
| 07/11/2007 | CN1994461A Lyophilization process of glutathione for injection |